Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Biogen, Fortinet, Kohl's, Pinterest, Snap and More Friday Afternoon Analyst Calls
11:50am, Friday, 05'th Feb 2021
With the trading day about halfway over, the broad markets were trading sideways into the weekend.
Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense
11:45am, Friday, 05'th Feb 2021
Jazz made a bold bet with the acquisition of GW Pharmaceuticals.
Is Now The Time to Buy Jazz Pharmaceuticals Stock?
07:20am, Friday, 05'th Feb 2021
This troubled biopharma is making a multi-billion dollar bet on the cannabis industry in hopes of a turnaround.
Jazz Pharmaceuticals to Acquire Cannabis Drug Company
02:23pm, Wednesday, 03'rd Feb 2021
The deal to buy GW Pharmaceuticals creates a leader in neuroscience.
Pot Stocks Are Wednesday's Big Stock Market Winners. Will They Disappoint Shareholders in the End?
12:18pm, Wednesday, 03'rd Feb 2021
In a quiet market, marijuana companies stood out.
GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal
11:35am, Wednesday, 03'rd Feb 2021
GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company. The post GWPH Stock: 12 Things to Know About the GW Pharma-Jazz
Jazz Pharma adds cannabis-based drug in $7.2 billion deal for GW Pharma
11:27am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding a cannabis-based epilepsy treatment.
Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
10:03am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding cannabis-based epilepsy treatment. CNBC's Ji
Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion
10:02am, Wednesday, 03'rd Feb 2021
Dublin-based Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) announced Wednesday morning that it has agreed to acquire London-based GW Pharmaceuticals PLC (NASDAQ: GWPH) for $220 per American depositary share
CBD Drug Makers, Medical Cannabis Stocks Rally On GW Pharma's Big Buyout
09:25am, Wednesday, 03'rd Feb 2021
Medical cannabis stocks and stocks of cannabinoid drug companies are rallying big time Wednesday, the catalyst being a multi-billion-dollar buyout in the space.
Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
08:46am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC's Becky Quick reports.
Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock
07:46am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals Plc said Wednesday it has agreed to acquire GW Pharmaceuticals Plc in a cash-and-stock deal valued at $7.2 billion. Under the terms of the deal, Jazz Pharma will pay $200 per shar
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
07:30am, Wednesday, 03'rd Feb 2021
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement
7 Pharmaceutical Stocks With Exciting Plans for 2021
02:51pm, Wednesday, 13'th Jan 2021
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
Jazz (JAZZ) Initiates BLA Submission for Leukemia Candidate
11:17am, Tuesday, 22'nd Dec 2020
Jazz (JAZZ) initiates the submission of a BLA to the FDA for the marketing approval of JZP-458 for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma.
